L3VLUP
ProSign in

TFX · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

TFXJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • TFX
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterTFXJNJ
Q3 202012 holders, $3.7bn30 holders, $26.2bn
Q4 202012 holders, $4.5bn32 holders, $26.6bn
Q1 20219 holders, $4.5bn31 holders, $25.3bn
Q2 202110 holders, $4.8bn37 holders, $25.6bn
Q3 202111 holders, $4.9bn40 holders, $24.1bn
Q4 202115 holders, $4.3bn33 holders, $25.2bn
Q1 202213 holders, $4.8bn35 holders, $28.2bn
Q2 202213 holders, $3.4bn33 holders, $26.9bn
Q3 202212 holders, $1.5bn36 holders, $25.4bn
Q4 202210 holders, $1.8bn35 holders, $27.6bn
Q1 20239 holders, $2.1bn42 holders, $24.5bn
Q2 20238 holders, $2.2bn38 holders, $25.0bn
Q3 202311 holders, $1.9bn37 holders, $18.9bn
Q4 20238 holders, $2.5bn31 holders, $19.0bn
Q1 20246 holders, $2.2bn32 holders, $19.7bn
Q2 202416 holders, $2.1bn35 holders, $20.4bn
Q3 202412 holders, $2.1bn28 holders, $22.3bn
Q4 202414 holders, $1.3bn37 holders, $20.4bn
Q1 202516 holders, $1.0bn32 holders, $20.5bn
Q2 202510 holders, $742m31 holders, $18.4bn
Q3 20259 holders, $1.0bn32 holders, $23.7bn
Q4 20259 holders, $989m29 holders, $27.8bn
Q1 202610 holders, $1.0bn34 holders, $35.6bn
Q2 20269 holders, $1.2bn33 holders, $39.1bn
TFX

Teleflex Inc

Holders
6
Reported value
$2.2bn
Buyers
2
Sellers
5

Breadth -3 among 93 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
32
Reported value
$19.7bn
Buyers
16
Sellers
13

Breadth +3 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2024

Among the 32 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only TFX (0)

None.

Only JNJ (26)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, Millennium Management LLC, Neuberger Berman Group LLC, Renaissance Technologies LLC, Squarepoint Ops LLC, Two Sigma Advisers LP, Two Sigma Investments LP, Verition Fund Management LLC, Voloridge Investment Management LLC, Walleye Capital LLC, and 1 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →